Fast Track and Breakthrough Therapy for Rare Diseases
Fast Track and Breakthrough Therapy for Rare Diseases Accelerating Rare Disease Therapies Through Fast Track and Breakthrough Designations The Need for Expedited Development in Rare Diseases Rare diseases—often debilitating, progressive, and life-threatening—affect millions worldwide, yet most lack approved treatments. Traditional drug development timelines spanning 10–15 years are incompatible with the urgent needs of rare disease…
Read More “Fast Track and Breakthrough Therapy for Rare Diseases” »